Project Scope
To understand the access challenges and price potential for an anticoagulation reversal agent in KSA
KSA
Challenge
Our client was looking to understand the access challenges and price potential for a product for the reversal of anticoagulation, to be used to resolve major bleeding events in patients treated with two specific direct-acting oral anticoagulants
Solution
- Conducted qualitative in-depth interviews with payers within Saudi Arabia
- Understood the landscape related to the reversal of uncontrolled bleeds in patients treated with DOACs
- Understood the clinical perceptions and market access potential of a new reversal agent
Results
- Enabled the client to understand the pricing and access potential for a new product within Saudi Arabia based on current and future evidence packages
- Enabled the client to understand specific nuances related to IRP and market access within KSA
Note: KSA: Kingdom of Saudi Arabia, DOACs: Direct acting oral anticoagulant, IRP: International Reference Pricing
